196 related articles for article (PubMed ID: 8832501)
21. Hydroxypropylcyclodextrins in parenteral use. I: Lipid dissolution and effects on lipid transfers in vitro.
Irie T; Fukunaga K; Pitha J
J Pharm Sci; 1992 Jun; 81(6):521-3. PubMed ID: 1522487
[TBL] [Abstract][Full Text] [Related]
22. Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity.
Hirayama F; Mieda S; Miyamoto Y; Arima H; Uekama K
J Pharm Sci; 1999 Oct; 88(10):970-5. PubMed ID: 10514341
[TBL] [Abstract][Full Text] [Related]
23. Effects of cyclodextrins on chlorpromazine-induced haemolysis and central nervous system responses.
Uekama K; Irie T; Sunada M; Otagiri M; Iwasaki K; Okano Y; Miyata T; Kasé Y
J Pharm Pharmacol; 1981 Nov; 33(11):707-10. PubMed ID: 6118408
[TBL] [Abstract][Full Text] [Related]
24. Bile acid and sterol solubilization in 2-hydroxypropyl-beta-cyclodextrin.
De Caprio J; Yun J; Javitt NB
J Lipid Res; 1992 Mar; 33(3):441-3. PubMed ID: 1569391
[TBL] [Abstract][Full Text] [Related]
25. Effects of aging on crystallization, dissolution and absorption characteristics of amorphous tolbutamide-2-hydroxypropyl-beta-cyclodextrin complex.
Kimura K; Hirayama F; Arima H; Uekama K
Chem Pharm Bull (Tokyo); 2000 May; 48(5):646-50. PubMed ID: 10823700
[TBL] [Abstract][Full Text] [Related]
26. Protective effects of cyclodextrins on drug-induced hemolysis in vitro.
Uekama K; Irie T; Sunada M; Otagiri M; Tsubaki K
J Pharmacobiodyn; 1981 Feb; 4(2):142-4. PubMed ID: 7277200
[TBL] [Abstract][Full Text] [Related]
27. Solid-state 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-alpha- and -beta-cyclodextrins.
Kimura K; Hirayama F; Arima H; Uekama K
Pharm Res; 1999 Nov; 16(11):1729-34. PubMed ID: 10571279
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the influence of some cyclodextrins on the stratum corneum from the hairless mouse.
Bentley MV; Vianna RF; Wilson S; Collett JH
J Pharm Pharmacol; 1997 Apr; 49(4):397-402. PubMed ID: 9232537
[TBL] [Abstract][Full Text] [Related]
29. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine.
Yoshida A; Yamamoto M; Itoh T; Irie T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):176-9. PubMed ID: 2337940
[TBL] [Abstract][Full Text] [Related]
30. Effect of hydroxypropyl-beta-cyclodextrin on the antimicrobial action of preservatives.
Lehner SJ; Müller BW; Seydel JK
J Pharm Pharmacol; 1994 Mar; 46(3):186-91. PubMed ID: 8027925
[TBL] [Abstract][Full Text] [Related]
31. Metronidazole/Hydroxypropyl-β-Cyclodextrin inclusion complex nanofibrous webs as fast-dissolving oral drug delivery system.
Celebioglu A; Uyar T
Int J Pharm; 2019 Dec; 572():118828. PubMed ID: 31715341
[TBL] [Abstract][Full Text] [Related]
32. Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether beta-cyclodextrin.
Nagase Y; Hirata M; Wada K; Arima H; Hirayama F; Irie T; Kikuchi M; Uekama K
Int J Pharm; 2001 Oct; 229(1-2):163-72. PubMed ID: 11604269
[TBL] [Abstract][Full Text] [Related]
33. Improvement of ursodeoxycholic acid bioavailability by 2-hydroxypropyl-beta-cyclodextrin complexation in healthy volunteers.
Panini R; Vandelli MA; Forni F; Pradelli JM; Salvioli G
Pharmacol Res; 1995; 31(3-4):205-9. PubMed ID: 7630860
[TBL] [Abstract][Full Text] [Related]
34. Inclusion complexation of p-hydroxybenzoic acid esters with 2-hydroxypropyl-beta-cyclodextrins. On changes in solubility and antimicrobial activity.
Matsuda H; Ito K; Sato Y; Yoshizawa D; Tanaka M; Taki A; Sumiyoshi H; Utsuki T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1448-52. PubMed ID: 8403092
[TBL] [Abstract][Full Text] [Related]
35. Fast-dissolving antioxidant curcumin/cyclodextrin inclusion complex electrospun nanofibrous webs.
Celebioglu A; Uyar T
Food Chem; 2020 Jul; 317():126397. PubMed ID: 32078994
[TBL] [Abstract][Full Text] [Related]
36. Folate-Appended Hydroxypropyl-β-Cyclodextrin Induces Autophagic Cell Death in Acute Myeloid Leukemia Cells.
Kubota Y; Hoshiko T; Higashi T; Motoyama K; Okada S; Kimura S
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069042
[TBL] [Abstract][Full Text] [Related]
37. Solid dispersion of hydroxypropyl beta-cyclodextrin and ketorolac: enhancement of in-vitro dissolution rates, improvement in anti-inflammatory activity and reduction in ulcerogenicity in rats.
Nagarsenker MS; Meshram RN; Ramprakash G
J Pharm Pharmacol; 2000 Aug; 52(8):949-56. PubMed ID: 11007065
[TBL] [Abstract][Full Text] [Related]
38. Effect of hydrotropic substances on the complexation of sparingly soluble drugs with cyclodextrin derivatives and the influence of cyclodextrin complexation on the pharmacokinetics of the drugs.
Müller BW; Albers E
J Pharm Sci; 1991 Jun; 80(6):599-604. PubMed ID: 1834826
[TBL] [Abstract][Full Text] [Related]
39. Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment.
Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):582-6. PubMed ID: 8882455
[TBL] [Abstract][Full Text] [Related]
40. Transdermal iontophoretic delivery of hydrocortisone from cyclodextrin solutions.
Chang SL; Banga AK
J Pharm Pharmacol; 1998 Jun; 50(6):635-40. PubMed ID: 9680073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
